Cantitate/Preț
Produs

Pediatric Drug Development Concepts and Applications 2e

Autor AE Mulberg
en Limba Engleză Hardback – 8 aug 2013

Most medicines have never been adequately tested for safety and efficacy in pediatric populations and preterm, infants and children are particularly vulnerable to adverse drug reactions.

Pediatric Drug Development: Concepts and Applications
, Second Edition, addresses the unique challenges in conducting effective drug research and development in pediatric populations.

This new edition covers the legal and ethical issues of consent and assent, the additional legal and safety protections for children, and the appropriate methods of surveillance and assessment for children of varying ages and maturity, particularly for patient reported outcomes. It includes new developments in biomarkers and surrogate endpoints, developmental pharmacology and other novel aspects of global pediatric drug development. It also encompasses the new regulatory initiatives across EU, US and ROW designed to encourage improved access to safe and effective medicines for children globally.

From an international team of expert contributors Pediatric Drug Development: Concepts and Applications is the practical guide to all aspects of the research and development of safe and effective medicines for children.

Citește tot Restrânge

Preț: 67144 lei

Preț vechi: 96436 lei
-30% Nou

Puncte Express: 1007

Preț estimativ în valută:
12850 13517$ 10722£

Carte indisponibilă temporar

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781118312155
ISBN-10: 1118312155
Pagini: 624
Dimensiuni: 196 x 247 x 34 mm
Greutate: 1.2 kg
Ediția:2nd Edition
Editura: Wiley
Locul publicării:Chichester, United Kingdom

Notă biografică


Descriere

Pediatric Drug Development, Second Edition, encompasses the new regulatory initiatives across EU, US and ROW designed to encourage improved access to safe and effective medicines for children. It includes new developments in biomarkers and surrogate endpoints, developmental pharmacology and other novel aspects of pediatric drug development.